Velicept Therapeutics

Small molecules for the treatment of overactive bladder (OAB) and irritable bowel syndrome (IBS).

placeMalvern, Pennsylvania, United States calendar_todayFounded 2015 groups8 employees language velicept.com

Registered entities

Innovation

9 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 1,222 times.

YearFilings
20163
20177
20183
20195
20206
20211
20241

Investor mix

5 investors on record; lead investors include Samsara BioCapital, Longitude Capital, CAM Capital.

Investor typeCountShare
Venture capital360%
Private equity120%
Other / undisclosed120%
Coming soon